WallStreetZenWallStreetZen

NYSE: PBH
Prestige Consumer Healthcare Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Prestige Consumer Healthcare earnings were $213.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest PBH earnings report on Dec 31, 2024 announced Q4 2024 earnings of $61.0M, up 12.2% from last quarter. For the last reported fiscal year 2024 ending Mar 31, 2024, PBH reported annual earnings of $209.3M, with -354.3% growth. The next PBH earnings date is May 8, 2025.

PBH past earnings growth

How has PBH's earnings growth performed historically?

Company
N/A
Industry
55.42%
Market
65.38%
PBH's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PBH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

PBH earnings history

Current Revenue
$1.1B
Current Earnings
$213.9M
Current Profit Margin
19.1%
PBH's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

PBH Return on Equity

Current Company
12.5%
Current Industry
12.5%
Current Market
34.1%
PBH's Return on Equity (12.5%)... subscribe to Premium to read more.
High Return on Equity Performance

PBH undefined

Current Company
6.4%
Current Industry
5.5%
PBH is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PBH announces earnings.

PBH undefined

Current Company
10.22%
Current Industry
12%
PBH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PBH vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PBH$367.43M$213.94M+6.82%$4.31
PRGO$421.90M-$171.80MN/A-$1.25
ALKS$489.79M$367.07M+3.74%$2.22
ELAN$1.39B$338.00M+30.45%$0.68
HCM$47.79M$37.73M-66.67%$0.20
View Top Pharmaceutical Stocks

PBH earnings dates

Next earnings date
May 8, 2025

Prestige Consumer Healthcare Earnings Reports & History FAQ

What were Prestige Consumer Healthcare's earnings last quarter?

On PBH's earnings call on Invalid Date, Prestige Consumer Healthcare (NYSE: PBH) reported Q4 2024 earnings per share (EPS) of $1.23, up 14.95% year over year. Total PBH earnings for the quarter were $61.03 million. In the same quarter last year, Prestige Consumer Healthcare's earnings per share (EPS) was $1.07.

If you're new to stock investing, here's how to buy Prestige Consumer Healthcare stock.

When does Prestige Consumer Healthcare report earnings?

The next PBH earnings date is Invalid Date. Add PBH to your watchlist to be reminded of Prestige Consumer Healthcare's next earnings date.

Is Prestige Consumer Healthcare profitable or losing money?

As of the last Prestige Consumer Healthcare earnings report, Prestige Consumer Healthcare is currently profitable. Prestige Consumer Healthcare's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $213.94 million, a 365.19% decrease year over year.

What was PBH's earnings growth in the past year?

As of Prestige Consumer Healthcare's earnings date in Invalid Date, Prestige Consumer Healthcare's earnings has grown year over year. PBH earnings in the past year totalled $213.94 million.

What are Prestige Consumer Healthcare's earnings expectations?

The current EPS estimate for Prestige Consumer Healthcare's earnings report in Invalid Date is $1.30.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.